Green Thumb Industries (OTC:GTBIF) Raised to “Strong-Buy” at Roth Capital

Roth Capital upgraded shares of Green Thumb Industries (OTC:GTBIFFree Report) to a strong-buy rating in a report issued on Sunday,Zacks.com reports.

Several other equities analysts also recently commented on the stock. Craig Hallum upgraded shares of Green Thumb Industries to a “strong-buy” rating in a research note on Monday, September 16th. Ventum Cap Mkts raised shares of Green Thumb Industries to a “strong-buy” rating in a report on Tuesday, August 6th.

Read Our Latest Stock Report on GTBIF

Green Thumb Industries Stock Up 14.7 %

OTC:GTBIF opened at $8.95 on Friday. Green Thumb Industries has a 12-month low of $7.50 and a 12-month high of $16.33. The company has a market capitalization of $1.89 billion, a price-to-earnings ratio of 33.15 and a beta of 1.40. The company has a 50 day simple moving average of $10.24.

Green Thumb Industries Company Profile

(Get Free Report)

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.

Read More

Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter.